Potent and Specific Inhibition of Human Leukocyte Elastase, Cathepsin G and Proteinase 3 by Sulfone Derivatives Employing the 1,2,5-Thiadiazolidin-3-one 1,1 Dioxide Scaffold
- 1 June 1998
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 6 (6) , 661-671
- https://doi.org/10.1016/s0968-0896(98)00006-6
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Structure-Based Design of a General Class of Mechanism-Based Inhibitors of the Serine Proteinases Employing a Novel Amino Acid-Derived Heterocyclic ScaffoldBiochemistry, 1997
- The Crystal Structure of PR3, a Neutrophil Serine Proteinase Antigen of Wegener's Granulomatosis AntibodiesJournal of Molecular Biology, 1996
- Lesional elastase activity in psoriasisArchives of Dermatological Research, 1995
- Nonpeptidic inhibitors of human leukocyte elastase. 5. Design, synthesis, and x-ray crystallography of a series of orally active 5-aminopyrimidin-6-one-containing trifluoromethyl ketonesJournal of Medicinal Chemistry, 1995
- Substituted 3-oxo-1,2,5-Thiadiazolidine 1,1-Dioxides: A New Class of Potential Mechanism-Based Inhibitors of Human Leukocyte Elastase and Cathepsin GBiochemical and Biophysical Research Communications, 1994
- Human neutrophil proteinase 3: Mapping of the substrate binding site using peptidyl thiobenzyl estersBiochemical and Biophysical Research Communications, 1992
- Orally active .beta.-lactam inhibitors of human leukocyte elastase-1. Activity of 3,3-diethyl-2-azetidinonesJournal of Medicinal Chemistry, 1992
- Substrate and inhibitor studies on proteinase 3FEBS Letters, 1992
- Evaluation of Elastase and Antielastase Balance in Patients with Chronic Bronchitis and Pulmonary EmphysemaAmerican Review of Respiratory Disease, 1990
- Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy.Journal of Clinical Investigation, 1990